Warner Bros. Discovery to Expand U.K. Studio, Following Netflix’s Playbook
Warner Bros. Discovery’s main studio in the U.K. is getting a major upgrade. The company is expanding its operation at Warner Bros. Studios Leavesden.
A take on business from Times Square
Sponsored by NYC News Service and CUNY Newmark J-School
Section
Warner Bros. Discovery’s main studio in the U.K. is getting a major upgrade. The company is expanding its operation at Warner Bros. Studios Leavesden.
Image by Mike Ramírez Mx from Pixabay Pharmaceutical giant Pfizer has teamed up with a biology biotech company Ginkgo Bioworks to research and develop RNA medicines, following a series of acquisitions and partnerships to grow and diversify its portfolio With the deal of up to $331 million the two companies plan to work on up to three
Lithium companies Livent and Allkem are moving ahead with a merger that would position the combined company to be the world’s third-largest producer in the market.
Rivian’s production is continuing to ramp up this year following an underperformance in 2022.
Mattel has promoted Robbie Brenner, the producer at the helm of the record-breaking “Barbie” movie, to president of the film division, the company said Thursday, a move that comes as the company plans over a dozen live-action releases centered around its characters.
Rivian’s boss isn’t afraid of the potential release of Tesla’s Cybertruck, a long-pledged electric truck that boasts a higher number of reservation requests than Rivian has cars on the road.
Falling lithium prices have sunk shares of major companies, but industry fundamentals are strong due to growing demand for electric car manufacturing
Stocks of prominent commercial airlines have experienced a decline in recent months owing to sluggish growth and rising fuel costs.
Draftkings, Caesars Entertainment and MGM Resorts International have been outperforming markets with sports betting expansion.
In the e-commerce sector, eBay is in the midst of a transformation, Wish is strategizing for growth and Etsy is contending with performance issues, attracting different levels of attention from investors and analysts.
Even though Covid-19 cases and hospitalization numbers are up, they won’t be a shot in the arm for either Moderna or Pfizer stock. Pfizer (NYSE:PFE) closed at $32.
Dollar stores are offering a different type of bargain these days: their stocks.
About the Journal
The Times Square Investment Journal covers companies, markets and personal finance from a newsroom in the heart of Manhattan. The Journal is sponsored by the NYC News Service and the Craig Newmark Graduate School of Journalism at CUNY.
Send comments and story tips to the editor.
greg.david@journalism.cuny.edu